TRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019
SAN DIEGO, Oct. 29, 2019 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development […]